Search CORE

5 research outputs found

Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma

Author: Andrea Salonia
Eugenio Ventimiglia
Pär Stattin
Stacy Loeb
US Food and Drug Administration FDA Adverse Events Reporting System (FAERS)
Yasin Folkvaljon
Publication venue: 'Oxford University Press (OUP)'
Publication date
Field of study

Safety evaluation of emicizumab prophylaxis in individuals with haemophilia A

Occupational and ambient radiation exposures from Lu-177 DOTATATE during targeted therapy

Author: A. Sulieman
B. Moftah
Bakker
Bandara
Bodei
Calais
Common Terminology Criteria for Adverse Events (CTCAE)
Cremonesi
D.A. Bradley
Demir
Eckert
Fareed H. Mayhoub
Food and Drug Administration (FDA)
Funkhouser
Gehan
H.I. Al-Mohammed
Hassan Salah
Horsch
Huizing
Kam
Kam
Kelkar
Kolasińska-Ćwikła
Kwekkeboom
Levart
M. Al Rowaily
M. Alkhorayef
Oliván-Sasot
Olmstead
Pillai
Sandström
Wang
Zaknun
Zou
Publication venue: 'Elsevier BV'
Publication date
Field of study

A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study

Author: Abizaid A
Aoki J
Babapulle MN
Bavry AA
Cook S
Cutlip DE
Daemen J
de Jaegere P
de Jaegere PP
Farb A
FDA advises physicians of adverse events associated with Cordis Cypher coronary stents.
Iakovou I
Keane D
Lemos PA
Lemos PA
Ludbrook J.
McFadden EP
Morice MC
Morice MC
Moses JW
Nakazawa G
Nebeker JR
Ong AT
Ozaki Y
Pfisterer M
Stone GW
Umans VA
Virmani R
Wenaweser P
Publication venue: 'Europa Digital & Publishing'
Publication date
Field of study

The Future of Drug Repositioning

Author: Almenoff
Ashburn
Bisson
Boguski
Bradley
Brogden
Buckley
Butcher
Carley
Carley
Cavalla
Center for World Health & Medicine at Saint Louis University
Chong
Chong
Clouser
Collaborative Drug Discovery
Compston
CTSA Clinical Translational Science Awards: Translating Discoveries to Medical Practice
CTSA Pharmaceutical Assets Portal
Cunha
Dietzsch
Dimond
Duenas-Gonzalez
Edwards
Eli Lilly Annual Reports
Engel
FDA Approves Cymbalta to Treat Chronic Musculoskeletal Pain
FDA Approves Drug for Neuropathic Pain Associated With Diabetes
FDA Approves Thalomid (thalidomide) to Treat Multiple Myeloma
Ferrari
Find the best treatments feel better faster
Fliri
Goldstein
Goldstein
Gourley
Gower
Haeberle
Hauben
Hopkins
Hopkins
Jarvis
Jimonet
Karin
Keiser
Kumar
Lum
Mark
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
Milan
Miller
Mulligan
Nare
New iPhone app tracks drug safety
New robot system to test 10 000 chemicals for toxicity
NIH researchers create comprehensive collection of approved drugs to identify new therapies for rare and neglected diseases
Okafor
Ouellet
Pfizer Financial Reports
Plosker
RADAR (Research on Adverse Drug events And Reports)
Richardson
Ripphausen
Rizo
Schoffski
Schubert
Schuffenhauer
Seeman
Skljarevski
Skljarevski
Sleigh
Sproxil Inc.
The Importance of Pharmacovigilance—Safety Monitoring of Medicinal Products
The Johns Hopkins Clinical Compound Screening Initiative
The NCGC Pharmaceutical Collection
Ting
Tobinick
Tsang
von Eichborn
Waknine
Waknine
Wang
Wermuth
Wlodkowic
Zon
Publication venue: 'Elsevier BV'
Publication date: 01/01/2011
Field of study

core

core